Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species

Transplantation Reviews

Volumn 26, Issue 2, 2012, Pages 103-114

  Jaeschke, Hartmut ^a   Woolbright, Benjamin L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; CD11B ANTIGEN; GLUTATHIONE; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; NORPHENAZONE; PLACEBO; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; CELL DAMAGE; CELL DEATH; HEPATIC ISCHEMIA REPERFUSION INJURY; HUMAN; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; KUPFFER CELL; LIPID PEROXIDATION; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW;

EID: 84858994511     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2011.10.006     Document Type: Review

References (169)

1. Nordstrom G., Seeman T., Hasselgren P.O. Beneficial effect of allopurinol in liver ischemia. Surgery 1985, 97:679-684.
2. Atalla S.L., Toledo-Pereyra L.H., MacKenzie G.H., et al. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985, 40:584-590.
3. Fernandez L., Heredia N., Grande L., et al. Preconditioning protects liver and lung damage in rat liver transplantation: role of xanthine/xanthine oxidase. Hepatology 2002, 36:562-572.
4. Metzger J., Dore S.P., Lauterburg B.H. Oxidant stress during reperfusion of ischemic liver: No evidence for a role of xanthine oxidase. Hepatology 1988, 8:580-584.
5. Jaeschke H., Smith C.V., Mitchell J.R. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J. Clin. Invest. 1988, 81:1240-1246.
6. Jaeschke H., Smith C.V., Mitchell J.R. Hypoxic damage generates reactive oxygen species in isolated perfused rat liver. Biochem. Biophys. Res. Commun. 1988, 150:568-574.
7. Jaeschke H., Mitchell J.R. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem. Biophys. Res. Commun. 1989, 160:140-147.
8. Engerson T.D., McKelvey T.G., Rhyne D.B., et al. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J. Clin. Invest. 1987, 79:1564-1570.
9. Hong J.Y., Lebofsky M., Farhood A., et al. Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis and JNK activation. Am. J. Physiol. Gastrointest. Liver. Physiol. 2009, 296:G572-G581.
10. Jeon B.R., Yeom D.H., Lee S.M., et al. Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver. Shock 2001, 15:112-117.
11. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J. Pharmacol. Exp. Ther. 1990, 255:935-941.
12. Knight T.R., Jaeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol. Appl. Pharmacol. 2002, 181:133-141.
13. Hirst J., King M.S., Pryde K.R. The production of reactive oxygen species by complex I. Biochem. Soc. Trans. 2008, 36:976-980.
14. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
15. Jaeschke H. Antioxidant defense mechanisms. Comprehensive Toxicology 2010, Vol 9:319-337. Academic Press, Oxford. C.A. McQueen (Ed.).
16. Kim I., Rodriguez-Enriquez S., Lemasters J.J. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 2007, 462:245-253.
17. Kim J.S., Nitta T., Mohuczy D., et al. Impaired autophagy: a mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology 2008, 5:1725-1736.
18. Wang J.H., Ahn I.S., Fischer T.D., et al. Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice. Gastroenterology 2011, 141:2188-2199.
19. Jaeschke H. Vascular oxidant stress and hepatic ischemia/reperfusion injury. Free Radic. Res. Commun. 1991, 12-13:737-743.
20. Jaeschke H., Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 1991, 260:G355-G362.
21. Caldwell-Kenkel J.C., Currin R.T., Tanaka Y., et al. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991, 13:83-95.
22. Jaeschke H., Bautista A.P., Spolarics Z., et al. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic. Res. Commun. 1991, 15:277-284.
23. Shibuya H., Ohkohchi N., Seya K., et al. Kupffer cells generate superoxide anions and modulate reperfusion injury in rat livers after cold preservation. Hepatology 1997, 25:356-360.
24. 2 release by activated Kupffer cells upon hypoxia-reoxygenation. Am. J. Physiol. 1991, 261:G602-G607.
25. Jaeschke H., Farhood A., Bautista A.P., et al. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am. J. Physiol. 1993, 264:G801-G809.
26. Liu P., McGuire G.M., Fisher M.A., et al. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995, 3:56-62.
27. Tsung A., Sahai R., Tanaka H., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 2005, 201:1135-1143.
28. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 1990, 192:245-261.
29. Jaeschke H. Enhanced sinusoidal glutathione efflux during endotoxin-induced oxidant stress in vivo. Am. J. Physiol. 1992, 263:G60-G68.
30. El-Benna J., Dang P.M., Gougerot-Pocidalo M.A. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin. Immunopathol. 2008, 30:279-289.
31. Jaeschke H., Farhood A., Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB. J. 1990, 4:3355-3359.
32. Jaeschke H., Bautista A.P., Spolarics Z., et al. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J. Leukocyte. Biol. 1992, 52:377-382.
33. Hasegawa T., Malle E., Farhood A., et al. Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning. Am. J. Physiol. Gastrointest. Liver. Physiol. 2005, 289:G760-G767.
34. Mavier P., Preaux A.M., Guigui B., et al. In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: evidence for a proteinase-mediated mechanism. Hepatology 1988, 8:254-258.
35. Harbrecht B.G., Billiar T.R., Curran R.D., et al. Hepatocyte injury by activated neutrophils in vitro is mediated by proteases. Ann. Surg. 1993, 218:120-128.
36. Jaeschke H. Mechanisms of neutrophil-mediated liver cell injury during ischemia-reperfusion and other acute inflammatory conditions. Am. J. Physiol. Gastrointest. Liver. Physiol. 2006, 290:G1083-G1088.
37. Jaeschke H., Ho Y.S., Fisher M.A., et al. Glutathione peroxidase deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: Importance of an intracellular oxidant stress. Hepatology 1999, 29:443-450.
38. Gujral J.S., Hinson J.A., Farhood A., et al. NADPH oxidase-derived oxidant stress is critical for neutrophil-induced cytotoxicity during endotoxemia. Am. J. Physiol. Gastrointest. Liver. Physiol. 2004, 287:G243-G252.
39. Gujral R.S., Farhood A., Bajt M.L., et al. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003, 38:355-363.
40. Nieminen A.L., Saylor A.K., Tesfai S.A., et al. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem. J. 1995, 307:99-106.
41. Nieminen A.L., Byrne A.M., Herman B., et al. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am. J. Physiol. 1997, 272:C1286-C1294.
42. Uchiyama A., Kim J.S., Kon K., et al. Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Hepatology 2008, 48:1644-1654.
43. Shappell S.B., Toman C., Anderson D.C., et al. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J. Immunol. 1990, 144:2702-2711.
44. Entman M.L., Youker K., Shoji T., et al. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J. Clin. Invest. 1992, 90:1335-1345.
45. Jaeschke H., Farhood A., Smith C.W. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol. 1991, 261:G1051-G1056.
46. Jaeschke H., Farhood A., Bautista A.P., et al. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993, 17:915-923.
47. Lehnert M., Arteel G.E., Smutney O.M., et al. Dependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock 2003, 19:345-351.
48. Dorman R.B., Wunder C., Saba H., et al. NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. Am. J. Physiol. Gastrointest. Liver. Physiol. 2006, 290:G1025-G1032.
49. Bamboat Z.M., Balachandran V.P., Ocuin L.M., et al. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010, 51:621-632.
50. Fan J., Li Y., Levy R.M., et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J. Immunol. 2007, 178:6573-6580.
51. Gill R., Tsung A., Billiar T. Linking oxidative stress to inflammation: toll-like receptors. Free Radic. Biol. Med. 2010, 48:1121-1132.
52. Negre-Salvayre A., Auge N., Ayala V., et al. Pathological aspects of lipid peroxidation. Free Radic. Res. 2010, 44:1125-1171.
53. Mathews W.R., Guido D.M., Fisher M.A., et al. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Radic. Biol. Med. 1994, 16:763-770.
54. Galley H.F., Richardson N., Howdle P.D., et al. Total antioxidant capacity and lipid peroxidation during liver transplantation. Clin. Sci. (Lond) 1995, 89:329-332.
55. Serrano E., Diaz J., Acosta F., et al. Relationship between cold ischemia time and lipid peroxidation in liver transplantation. Transplant. Proc. 2000, 32:2648.
56. Risby T.H., Maley W., Scott R.P., et al. Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic liver transplants. Surgery 1994, 115:94-101.
57. Parola M., Bellomo G., Robino G., et al. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox. Signal. 1999, 1:255-284.
58. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J. Gastroenterol. Hepatol. 2011, 26(Suppl 1):173-179.
59. Lemasters J.J., Qian T., He L., et al. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid. Redox. Signal. 2002, 4:769-781.
60. He L., Lemasters J.J. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?. FEBS. Lett. 2002, 512:1-7.
61. Theruvath T.P., Zhong Z., Pediaditakis P., et al. Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology 2008, 1:236-246.
62. Zhong Z., Ramshesh V.K., Rehman H., et al. Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver. Physiol. 2008, 95:G823-G832.
63. Molchanova L.V., Nickulina S.E., Ivanova T.N., et al. Role of cAMP in regulation of activity of acid hydrolases of rat heart and liver during ischemia and after recirculation. Resuscitation 1991, 22:261-274.
64. Grek O.R., Pupyshev A.B., Tikhonova E.V. Effect of transitory ischemia on liver lysosomal apparatus in rats with different resistance to hypoxia. Bull. Exp. Biol. Med. 2003, 136:11-13.
65. Rüdiger H.A., Graf R., Clavien P.A. Liver ischemia: apoptosis as a central mechanism of injury. J. Invest. Surg. 2003, 16:149-159.
66. Jones B.E., Lo C.R., Liu H., et al. Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver. Physiol. 2000, 278:G693-G699.
67. Conde de la Rosa L., Schoemaker M.H., Vrenken T.E., et al. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J. Hepatol. 2006, 44:918-929.
68. Singh R., Czaja M.J. Regulation of hepatocyte apoptosis by oxidative stress. J. Gastroenterol. Hepatol. 2007, 22(Suppl 1):S45-S48.
69. Yan H.M., Ramachandran A., Bajt M.L., et al. The oxygen tension modulates acetaminophen-induced mitochondrial oxidant stress and cell injury in cultured hepatocytes. Toxicol. Sci. 2010, 117:515-523.
70. Jaeschke H., Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003, 125:1246-1257.
71. Gujral J.S., Bucci T.J., Farhood A., et al. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?. Hepatology 2001, 33:397-405.
72. Gerwig T., Meissner H., Bilzer M., et al. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J. Hepatol. 2003, 39:341-348.
73. Jaeschke H., Gujral J.S., Bajt M.L. Apoptosis and necrosis in liver disease. Liver. Int. 2004, 24:85-89.
74. Baskin-Bey E.S., Washburn K., Feng S., et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am. J. Transplant. 2007, 7:218-225.
75. Schotte P., Declercq W., Van Huffel S., et al. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS. Lett. 1999, 442:117-121.
76. Kohli V., Gao W., Camargo C.A., et al. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9354-9359.
77. Baskin-Bey E.S., Canbay A., Bronk S.F., et al. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am. J. Physiol. Gastrointest. Liver. Physiol. 2005, 288:G396-G402.
78. Klaassen C.D., Reisman S.A. Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol. Appl. Pharmacol. 2010, 244:57-65.
79. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
80. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 2011, 85:241-272.
81. Yuan L., Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol. Aspects. Med. 2009, 30:29-41.
82. Lu S.C. Regulation of glutathione synthesis. Mol. Aspects. Med. 2009, 30:42-59.
83. Liu P., Fisher M.A., Farhood A., et al. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ. Shock. 1994, 43:64-70.
84. Knight T.R., Ho Y.S., Farhood A., et al. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J. Pharmacol. Exp. Ther. 2002, 303:468-475.
85. Schauer R.J., Kalmuk S., Gerbes A.L., et al. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World. J. Gastroenterol. 2004, 10:864-870.
86. Schauer R.J., Gerbes A.L., Vonier D., et al. Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia. Ann. Surg. 2004, 239:220-231.
87. Bilzer M., Baron A., Schauer R., et al. Glutathione treatment protects the rat liver against injury after warm ischemia and Kupffer cell activation. Digestion 2002, 66:49-57.
88. Smyrniotis V., Arkadopoulos N., Kostopanagiotou G., et al. Attenuation of ischemic injury by N-acetylcysteine preconditioning of the liver. J. Surg. Res. 2005, 129:31-37.
89. Nagasaki H., Nakano H., Boudjema K., et al. Efficacy of preconditioning with N-acetylcysteine against reperfusion injury after prolonged cold ischaemia in rats liver in which glutathione had been reduced by buthionine sulphoximine. Eur. J. Surg. 1998, 164:139-146.
90. Fusai G., Glantzounis G.K., Hafez T., et al. N-acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin. Sci. (Lond). 2005, 109:465-473.
91. Sener G., Tosun O., Sehirli A.O., et al. Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life. Sci. 2003, 72:2707-2718.
92. Saito C., Zwingmann C., Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 2010, 51:246-254.
93. Wendel A., Cikryt P. The level and half-life of glutathione in human plasma. FEBS. Lett. 1980, 120:209-211.
94. Jegatheeswaran S., Siriwardena A.K. Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB. (Oxford). 2011, 13:71-78.
95. Peralta C., León O.S., Xaus C., et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic. Res. 1999, 31:191-196.
96. Shen S.Q., Zhang Y., Xiang J.J., et al. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World. J. Gastroenterol. 2007, 13:1953-1961.
97. Rao J., Zhang C., Wang P., et al. All-trans retinoic acid alleviates hepatic ischemia/reperfusion injury by enhancing manganese superoxide dismutase in rats. Biol. Pharm. Bull. 2010, 33:869-875.
98. Pardo M., Budick-Harmelin N., Tirosh B., et al. Antioxidant defense in hepatic ischemia-reperfusion injury is regulated by damage-associated molecular pattern signal molecules. Free Radic. Biol. Med. 2008, 45:1073-1083.
99. Yabe Y., Kobayashi N., Nishihashi T., et al. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J. Pharmacol. Exp. Ther. 2001, 298:894-899.
100. Wheeler M.D., Katuna M., Smutney O.M., et al. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum. Gene. Ther. 2001, 12:2167-2177.
101. Suzuki M., Takeuchi H., Kakita T., et al. The involvement of the intracellular superoxide production system in hepatic ischemia-reperfusion injury. In vivo and in vitro experiments using transgenic mice manifesting excessive CuZn-SOD activity. Free Radic. Biol. Med. 2000, 29:756-763.
102. Takeda A., Onodera H., Sugimoto A., et al. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain. Res. 1994, 666:120-124.
103. Maines M.D., Mayer R.D., Ewing J.F., et al. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J. Pharmacol. Exp. Ther. 1993, 264:457-462.
104. Yamaguchi T., Terakado M., Horio F., et al. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem. Biophys. Res. Commun. 1996, 223:129-135.
105. Amersi F., Buelow R., Kato H., et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 1999, 104:1631-1639.
106. Schmidt R., Tritschler E., Hoetzel A., et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann. Surg. 2007, 245:931-942.
107. Man K., Ng K.T., Lee T.K., et al. FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am. J. Transplant. 2005, 5:40-49.
108. Ke B., Shen X.D., Lassman C.R., et al. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am. J. Transplant. 2003, 3:1076-1082.
109. Amersi F., Shen X.D., Anselmo D., et al. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 2002, 35:815-823.
110. Kume M., Yamamoto Y., Saad S., et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J. Lab. Clin. Med. 1996, 128:251-258.
111. Tsuchihashi S., Fondevila C., Kupiec-Weglinski J.W. Heme oxygenase system in ischemia and reperfusion injury. Ann. Transplant. 2004, 9:84-87.
112. de Rougemont O., Lehmann K., Clavien P.A. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver. Transpl. 2009, 15:1172-1182.
113. Sindram D., Rüdiger H.A., Upadhya A.G., et al. Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J. Hepatol. 2002, 36:78-84.
114. Carini R., De Cesaris M.G., Splendore R., et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001, 33:131-139.
115. Peralta C., Bulbena O., Xaus C., et al. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002, 73:1203-1211.
116. Serafín A., Fernández-Zabalegui L., Prats N., et al. Ischemic preconditioning: tolerance to hepatic ischemia-reperfusion injury. Histol. Histopathol. 2004, 19:281-289.
117. Schauer R.J., Gerbes A.L., Vonier D., et al. Induction of cellular resistance against Kupffer cell-derived oxidant stress: a novel concept of hepatoprotection by ischemic preconditioning. Hepatology 2003, 37:286-295.
118. Teoh N., Dela Pena A., Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 2002, 36:94-102.
119. Clavien P.A., Yadav S., Sindram D., et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann. Surg. 2000, 232:155-162.
120. Clavien P.A., Selzner M., Rüdiger H.A., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann. Surg. 2003, 238:843-850.
121. Jassem W., Fuggle S.V., Cerundolo L., et al. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006, 81:169-174.
122. Jassem W., Fuggle S., Thompson R., et al. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation. Liver. Transpl. 2009, 15:1750-1765.
123. Dal Ponte C., Alchera E., Follenzi A., et al. Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury. Liver. Transpl. 2011, 17:474-482.
124. Guo Y., Yang T., Lu J., et al. Rb1 postconditioning attenuates liver warm ischemia-reperfusion injury through ROS-NO-HIF pathway. Life. Sci. 2011, 88:598-605.
125. Wang Y., Mathews W.R., Guido D.M., et al. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 1995, 4:282-288.
126. Wang Y., Lawson J.A., Jaeschke H. Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia. Shock 1998, 10:20-25.
127. Carini R., De Cesaris M.G., Splendore R., et al. Ischemic preconditioning reduces Na(+) accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatology 2000, 31:166-172.
128. Hart M.L., Much C., Gorzolla I.C., et al. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 2008, 135:1739-1750.
129. Nakayama H., Yamamoto Y., Kume M., et al. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999, 126:945-954.
130. Arai M., Thurman R.G., Lemasters J.J. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000, 32:297-302.
131. Arai M., Tejima K., Ikeda H., Tomiya T., Yanase M., Inoue Y., Nagashima K., Nishikawa T., Watanabe N., Omata M., Fujiwara K. Ischemic preconditioning in liver pathophysiology. J. Gastroenterol. Hepatol. 2007, (Suppl 1):S65-S67.
132. Gerbes A.L., Vollmar A.M., Kiemer A.K., et al. The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 1998, 28:1309-1317.
133. Kiemer A.K., Gerbes A.L., Bilzer M., et al. The atrial natriuretic peptide and cGMP: novel activators of the heat shock response in rat livers. Hepatology 2002, 35:88-94.
134. Bilzer M., Jaeschke H., Vollmar A.M., et al. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am. J. Physiol. 1999, 276:G1137-G1144.
135. Lv X., Yang L., Tao K., et al. Isoflurane preconditioning at clinically relevant doses induce protective effects of heme oxygenase-1 on hepatic ischemia reperfusion in rats. BMC. Gastroenterol. 2011, 11:31.
136. Beck-Schimmer B., Breitenstein S., Urech S., et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann. Surg. 2008, 248:909-918.
137. Zhang L., Huang H., Cheng J., et al. Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice. Life. Sci. 2011, 88:1102-1107.
138. Babior B.M., Lambeth J.D., Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 2002, 397:342-344.
139. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver. Physiol. 2003, 284:G15-G26.
140. Jaquet V., Scapozza L., Clark R.A., et al. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid. Redox. Signal. 2009, 11:2535-2552.
141. Liu P.G., He S.Q., Zhang Y.H., et al. Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice. World. J. Gastroenterol. 2008, 14:2832-2837.
142. Dove A. CD18 trials disappoint again. Nat. Biotechnol. 2000, 18:817-818.
143. Rhee P., Morris J., Durham R., et al. Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group. J. Trauma. 2000, 49:611-619.
144. Kantrow S.P., Tatro L.G., Piantadosi C.A. Oxidative stress and adenine nucleotide control of mitochondrial permeability transition. Free Radic. Biol. Med. 2000, 28:251-260.
145. Theruvath T.P., Snoddy M.C., Zhong Z., et al. Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. Transplantation 2008, 85:1500-1504.
146. Okatani Y., Wakatsuki A., Reiter R.J., et al. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. Eur. J. Pharmacol. 2003, 469:145-152.
147. Okatani Y., Wakatsuki A., Enzan H., et al. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver. Eur. J. Pharmacol. 2003, 465:163-170.
148. Eismann T., Huber N., Shin T., et al. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am. J. Physiol. Gastrointest. Liver. Physiol. 2009, 296:G266-G274.
149. Hanawa N., Shinohara M., Saberi B., et al. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J. Biol. Chem. 2008, 283:13565-13577.
150. Saito C., Lemasters J.J., Jaeschke H. c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 2010, 246:8-17.
151. Edeas M. Strategies to target mitochondria and oxidative stress by antioxidants: key points and perspectives. Pharm. Res. 2011, 28:2771-2779.
152. Watanabe T., Tahara M., Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc. Ther. 2008, 26:101-114.
153. Ninomiya M., Shimada M., Harada N., et al. Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. Transplantation 2002, 74:1470-1472.
154. Abe T., Unno M., Takeuchi H., et al. A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo. J. Gastrointest. Surg. 2004, 8:604-615.
155. Suzuki F., Hashikura Y., Ise H., et al. MCI-186 (edaravone), a free radical scavenger, attenuates hepatic warm ischemia-reperfusion injury in rats. Transpl. Int. 2005, 18:844-853.
156. Ninomiya M., Shimada M., Harada N., et al. The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischaemia-reperfusion injury. Br. J. Surg. 2004, 91:184-190.
157. Totsuka O., Takeyoshi I., Tsutsumi H., et al. Effects of a free radical scavenger, MCI-186, on ischemia-reperfusion injury during extended liver resection in dogs. Hepatogastroenterology 2005, 52:1545-1548.
158. Rigotti A. Absorption, transport, and tissue delivery of vitamin. E. Mol. Aspects Med. 2007, 28:423-436.
159. Marubayashi S., Dohi K., Ochi K., et al. Role of free radicals in ischemic rat liver cell injury: prevention of damage by alpha-tocopherol administration. Surgery 1986, 99:184-192.
160. Bartels M., Biesalski H.K., Engelhart K., et al. Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial. Clin. Nutr. 2004, 23:1360-1370.
161. Koga H., Hagiwara S., Inomata M., et al. Vitamin E derivative ETS-GS reduces liver ischemia-reperfusion injury in rats. J. Surg. Res. 2011, in press.
162. Hassan-Khabbar S., Cottart C.H., Wendum D., et al. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery. Liver Transpl. 2008, 14:451-459.
163. Gedik E., Girgin S., Ozturk H., et al. Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J. Gastroenterol. 2008, 14:7101-7106.
164. Sehirli O., Ozel Y., Dulundu E., et al. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother. Res. 2008, 22:43-48.
165. Liang R., Nickkholgh A., Kern M., et al. Green tea extract ameliorates reperfusion injury to rat livers after warm ischemia in a dose-dependent manner. Mol. Nutr. Food Res. 2011, 55:855-863.
166. Peters C.M., Green R.J., Janle E.M., et al. Formulation with ascorbic acid and sucrose modulates catechin bioavailability from green tea. Food Res. Int. 2010, 43:95-102.
167. Cheng F., Li Y., Feng L., Li S. Effects of tetrandine on ischemia/reperfusion injury in mouse liver. Transplant. Proc. 2008, 40:2163-2166.
168. Su J.F., Guo C.J., Wei J.Y., et al. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed. Environ. Sci. 2003, 16:1-8.
169. Firuzi O., Miri R., Tavakkoli M., et al. Antioxidant therapy: current status and future prospects. Curr. Med. Chem. 2011, 18:3871-3888.